From: Anti-infliximab antibodies are already detectable in most patients with rheumatoid arthritis halfway through an infusioncycle: an open-label pharmacokinetic cohort study
Prior to
infusion
1 hour after
50% of the
infusioncycle
75% of the
100% of the
Median infliximab levels
Median infliximab levels (p25-p75)
0.6 (0.0 - 3.1)
77.0 (65-89)
5.9 (1.5-13)
2.7 (0.2-5.7)
0.0 (0.0-3.1).